No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

Fibrobiologics' cell therapy CYMS101 significantly increased myelin production and promoted myelin repair in a mouse model of MS ...

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...

San Diego to raise awareness and funds to find a cure for multiple sclerosis. Hosted by the National Multiple Sclerosis ...

In a recent case report published in Frontiers in Immunology, scientists in Canada described how an experimental treatment ...

Observational studies and two randomized controlled trials consistently suggest that, in general, disease recurrence after ...

A local naval officer is fearlessly facing his multiple sclerosis diagnosis, using his creativity and entrepreneurial skills ...

Roche Holdings AG (OTC:RHHBY) on Wednesday announced data from MUSETTE Phase 3 trial of a high dose of Ocrevus (ocrelizumab) ...

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...